-
WGS of gastric cancer in the Japanese population (81 gastric cancers of NCC)
Study
EGAS00001006051
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
Targeted sequencing of breast cancer susceptibility genes for 1,995 Japanese breast cancer patients
Study
EGAS00001004630
-
MutWP5__CRUK_Mutographs_of_Cancer__Lung__PD38234__WG_
Study
EGAS00001003324
-
Res1_H23_exp1_MC_04_03_22
Study
EGAS00001006091
-
Genomic profiling of Follicular thyroid adenomas and carcinomas using exome-sequencing analyses
Study
EGAS00001005561
-
Targeting AXL Kinase Uniquely Sensitizes Therapy-Insensitive Leukemic Stem and Progenitor Cells to Venetoclax Treatment in Acute Myeloid Leukemia
Study
EGAS00001004663
-
Transcriptomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum
Study
EGAS00001004668
-
To determine the genomic profiles of Triple Negative Breast Cancers (COH cohort)
Study
EGAS00001006085
-
Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer
Study
EGAS00001003352
-
Exploration of coding and non-coding variants in cancer using GenomePaint.
Study
EGAS00001004669
-
mutational landscape of normal human breast
Study
EGAS00001004672
-
Res1_HT29_exp1_MC_02_03_22
Study
EGAS00001006092
-
Molecular analysis of FIT interval colorectal cancers
Study
EGAS00001004683
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_oncoscan)
Study
EGAS00001005586
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_agilent)
Study
EGAS00001005587
-
Allele-specific expression of GATA2 due to epigenetic dysregulation in double mutated CEBPA AML
Study
EGAS00001004684
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-5)
Study
EGAS00001006114
-
Salivary Gland Cancer TSO500 dataset
Study
EGAS00001006232
-
A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Study
EGAS00001004704
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
Res1_PC9_exp1_MC_29_03_22
Study
EGAS00001006169
-
A novel orthotopic patient-derived xenograft model of radiation-induced glioma following medulloblastoma
Study
EGAS00001004709
-
Organoid_Derivation_Project___GRCh38___WGS
Study
EGAS00001004712
-
Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer
Study
EGAS00001003367
-
The genomic landscape of serrated lesion of the colorectum
Study
EGAS00001005648
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers
Study
EGAS00001006175
-
MCO colorectal cancer genomics at UNSW
Study
EGAS00001003450
-
Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient
Study
EGAS00001004857
-
UROMOL 2020 - SNP data
Study
EGAS00001004862
-
Proteogenomics of chronic lymphocytic leukemia
Study
EGAS00001005746
-
Accurate detection of tumor-specific fusion genes reveals strongly immunogenic personal neo-antigens
Study
EGAS00001004877
-
Single_cell_characterization_of_T_cell_lymphoma_
Study
EGAS00001005750
-
Somatic_mutation_and_clonal_evolution_in_the_human_bladder_Novaseq
Study
EGAS00001003433
-
Functional and genomic heterogeneity of long-term self-renewing compartment as the origin of treatment resistance in pancreatic tumors
Study
EGAS00001003442
-
Whole-exome sequencing of paired tumour/blood of 58 T1 stage bladder cancer patients
Study
EGAS00001005765
-
Heat selection enables highly scalable methylome profiling in cell-free DNA for noninvasive monitoring of cancer patients
Study
EGAS00001006198
-
Analysis of error profiles in deep next-generation sequencing data
Study
EGAS00001003444
-
Defining structural variation associated with breast cancer susceptibility by long-read genome sequencing
Study
EGAS00001005872
-
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Study
EGAS00001005876
-
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Study
EGAS00001006200
-
WXS and RNA-seq for 22 patients treated with radiation + immunotherapy
Study
EGAS00001006212
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
Targeted_NanoSeq_Sperm
Study
EGAS00001005920
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
RNA-seq on patient-derived, stage II, CRC cell lines
Study
EGAS00001005948
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
RNA-sequencing data from metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study
EGAS00001005954
-
An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs
Study
EGAS00001005974
-
Combined gene expression and digital pathology identifies molecular mediators of T cell exclusion and immune suppression in ovarian cancer
Study
EGAS00001003487
-
Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers
Study
EGAS00001006331
-
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH_TNBC_RNAseq)
Study
EGAS00001006002
-
Clonal dominance defines metastatic dissemination in pancreatic cancer
Study
EGAS00001006358
-
Single cell RNA sequencing of colorectal cancer patients (CRC-SG1)
Study
EGAS00001006013
-
Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
Study
EGAS00001003497
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (ChIP-seq)
Study
EGAS00001006017
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-2)
Study
EGAS00001006039
-
Comparison of sequencing assays for sensitive detection of circulating tumour DNA in stage IA-IV breast cancer
Study
EGAS00001006040
-
Single cell RNA sequencing of colorectal cancer patients (KUL3/KUL5)
Study
EGAS00001006049
-
Application of high-throughput, high-depth, targeted single-nucleus DNA sequencing in pancreatic cancer
Study
EGAS00001006024
-
CD8+ Tumor-Infiltrating Lymphocyte Abundance is a Positive Prognostic Indicator in Nasopharyngeal Cancer
Study
EGAS00001006396
-
Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies unique proteotypes associated with patient outcomes
Study
EGAS00001006068
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-4)
Study
EGAS00001006101
-
whole-genome sequencing of gastric cancer
Study
EGAS00001003512
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123
-
MutWP4__CRUK_Grand_Challenge_Mutographs_of_Cancer__Pancreatic_Organoids
Study
EGAS00001003520
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
DNA methylation-based prognostic subtypes of chordoma tumors in tissue
Study
EGAS00001006406
-
Phase 1 CX-5461 Trial (Canadian Cancer Trials Group Trial IND.231)
Study
EGAS00001006173
-
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Study
EGAS00001006293
-
Prostate cancer ancestral genomic disparity
Study
EGAS00001006425
-
MutWP5__CRUK_Mutographs_of_Cancer__Cancer_Mastectomy__Exome__Novaseq_
Study
EGAS00001003528
-
Molecular Classification of Hormone Sensitive and Castration Resistant prostate cancer, using non-negative matrix factorization molecular subtyping
Study
EGAS00001006204
-
Melanoma_post_mortem_analysis
Study
EGAS00001003531
-
Germline sequencing
Study
EGAS00001006254
-
Immune induction strategies to enhance the sensitivity to PD-1 blockade in metastatic triple negative breast cancer: the TONIC-trial
Study
EGAS00001003535
-
Germline variant analysis in childhood AML
Study
EGAS00001006276
-
Deep whole genome sequencing identifies recurrent genomic alterations in breast cancer cell lines and patient derived xenograft models
Study
EGAS00001006285
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001006306
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma___2
Study
EGAS00001003542
-
Childhood Cancer Model Atlas
Study
EGAS00001006320
-
RNA sequencing of NK cells in human lung
Study
EGAS00001003544
-
Genetic and epigenetic variation at regulatory regions contribute to cancer evolution under endocrine treatment
Study
EGAS00001006340
-
Placental_mosaicism
Study
EGAS00001003549
-
Arriba: accurate and efficient detection of gene fusions from RNA-Seq (H021)
Study
EGAS00001003554
-
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients
Study
EGAS00001003563
-
Widespread hypertranscription in aggressive human cancers
Study
EGAS00001006365
-
Tumor microenvironment study of ovarian granulosa cell tumors
Study
EGAS00001006478
-
RNA-seq analysis of metastatic prostate cancer solid tumor biopsies
Study
EGAS00001006369
-
Somatic_mutation_in_edited_cholangiocyte_organoids_NanoSeq
Study
EGAS00001006405
-
Finding structural variation from the human skin fibroblast at the single-cell level
Study
EGAS00001006498
-
Plasma whole genome sequencing from patients with stage IV colorectal cancer and microsatellite instability
Study
EGAS00001006377
-
Dedifferentiated_Melanoma_RNAseq
Study
EGAS00001003601
-
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers
Study
EGAS00001006393
-
Resolving the immune landscape of human prostate at a single cell level in health and cancer
Study
EGAS00001005787
-
Colorectal cancer transcriptomics with primary and metastatic samples
Study
EGAS00001006464